Azora Therapeutics, Inc.
corporate_fare Company Profile
Azora Therapeutics, Inc. (NASDAQ:AZR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for AZR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 7/10. Across its 2 most recent items scored 7 or higher, the top rating is 7/10. Recent SEC coverage for AZR spans S-3.
Recent high-impact activity:
- Azora Files $250M Shelf and $20M Jefferies ATM, Replacing A.G.P. Program
- Q3 Loss Widens to $64.6M on $57.1M Non-Cash Warrant Charge; Cash Falls to $22M
Financial Snapshot
Short Interest & Short Volume
4.13 days to coverFINRA reported short interest of 217,174 shares in AZR as of the October 30, 2026 settlement, a 20.9% increase from the prior period — about 4.1 days to cover at its recent average daily volume. On November 20, 2026, 4.6% of AZR volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for AZR, detected from its recent SEC filings.
New $250M Shelf and $20M ATM · Prior ATM Terminated
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →